Results 91 to 100 of about 978,166 (202)

Indolent systemic mastocytosis limited to the bone: a case report and review of the literature

São Paulo Medical Journal
CONTEXT Systemic mastocytosis is defined as a clonal disorder of mast cells and their precursor cells and is currently classified as a myeloproliferative neoplasm.
Pedro Pinto-Lopes, Francisco Adao Fonseca, Roberto Silva, Pedro von Hafe, Elsa Fonseca   +4 more
doaj   +1 more source

Mastocytosis: One Word for Different Diseases

Oncology and Therapy, 2018
Mastocytosis is a neoplastic disease originating from tissue infiltration by transformed mast cells. The diagnosis requires a high grade of suspicion due to the large variety of presenting symptoms. The World Health Organization classification recognizes
Marianna Criscuolo, Luana Fianchi, Alessio M. E. Maraglino, Livio Pagano   +3 more
doaj   +1 more source

Interferon-α treatment in systemic mastocytosis

, 2011
Patients with systemic mastocytosis are rare, constitute a heterogeneous clinical entity and some may not require treatment until long after diagnosis.
Bjerrum, Ole Weis
core   +1 more source

Concurrent acute myeloid leukemia and systemic mastocytosis

, 1991
A 51 -year-old woman presented with concurrent systemic mastocytosis and acute myeloid leukemia associated with a clonal karyotypic anomaly of t(8;21). Cytochemical, histologic, and cytogenetic studies helped in the distinction from a recently described ...
Ma, SK, Kwong, YL, Chow, TC, T. C. Chow, Y. L. Kwong, Chan, JCW, K. F. Wong, Chan, JKC, J. K. C. Chan, S. K. Ma, Wong, KF, J. C. W. Chan   +11 more
core   +1 more source

Recurrent prosthetic mitral valve thrombosis: The first report of an unusual feature of systemic mastocytosis, a case report and review of the literature. [PDF]

Caspian Journal of Internal Medicine
Background: Mastocytosis is a systemic disease involving the clonal expansion of mast cells in multiple organs. Given that immune system overreaction and excessive histamine release are among the most prominent events in mastocytosis, the incidence of ...
Amirhossein Akbarzadehpasha, Zahra Lotfi, Razieh Omidvar, Azadeh Goodarzi, Saeid Hosseini, Afsaneh Sadeghzadeh Bazargan, Kambiz Kamyab Hesari   +6 more
doaj  

Clinical potential of midostaurin in advanced systemic mastocytosis

, 2017
Marie Olivia Chandesris,1–3 Gandhi Damaj,1,4 Olivier Lortholary,1,3,5 Olivier Hermine1–3,6 On behalf of the CEREMAST study group 1French Reference Center for Mastocytosis (CEREMAST), 2Department of Hematology, Necker Children’s Hospital,
Hermine O, Lortholary O, Chandesris MO, Damaj G   +3 more
core  

Bullous mastocytosis

Indian Journal of Dermatology, 2007
Mastocytosis is a condition characterized by the disorderly infiltration of mast cells in several tissues and comprises many different clinical situations varying from indolent cutaneous forms to malignant and systemic conditions. Bullous mastocytosis is
Nayak Surajit, Acharjya Basanti, Devi Basanti, Behera Samira   +3 more
doaj  

Novel approaches to treating advanced systemic mastocytosis

Clinical Pharmacology: Advances and Applications, 2019
JA Gilreath,1 L Tchertanov,2 MW Deininger31Department of Pharmacotherapy, College of Pharmacy and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA; 2Centre de Mathématiques et de Leurs Applications (CMLA-CNRS), ENS ...
Gilreath JA, Tchertanov L, Deininger MW
doaj  

Aortic valve replacement in patients with systemic mastocytosis.

, 2012
Systemic mastocytosis is a hematologic disorder with important perioperative implications. A variety of stimuli and medications can cause severe anaphylaxis in these patients.
Magovern, George J, Moraca, Robert J, Wanamaker, Kelly M   +2 more
core   +1 more source

Diffuse osteosclerosis in a patient with systemic mastocytosis. [PDF]

JCEM Case Rep
Do HH, Krishnamurthy B, Grill V, Leow C, Nguyen HH.   +4 more
europepmc   +1 more source